BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33928351)

  • 1. Control of Breast Cancer Pathogenesis by Histone Methylation and the Hairless Histone Demethylase.
    Trager MH; Sah B; Chen Z; Liu L
    Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33928351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairless is a histone H3K9 demethylase.
    Liu L; Kim H; Casta A; Kobayashi Y; Shapiro LS; Christiano AM
    FASEB J; 2014 Apr; 28(4):1534-42. PubMed ID: 24334705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone methyl-transferases and demethylases in the autophagy regulatory network: the emerging role of KDM1A/LSD1 demethylase.
    Ambrosio S; Ballabio A; Majello B
    Autophagy; 2019 Feb; 15(2):187-196. PubMed ID: 30208749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controllers of histone methylation-modifying enzymes in gastrointestinal cancers.
    Li L; Song Q; Zhou J; Ji Q
    Biomed Pharmacother; 2024 May; 174():116488. PubMed ID: 38520871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity.
    Shen Y; Singh J; Sah B; Chen Z; Ha W; Henzler C; Su T; Xie L; Deng Y; Li G; Guo H; Hibshoosh H; Liu L
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of histone methylation in skin cancers: Histone methylation-modifying enzymes as a new class of targets for skin cancer treatment.
    Sutopo NC; Kim JH; Cho JY
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188865. PubMed ID: 36841366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers.
    Maatough A; Whitfield GK; Brook L; Hsieh D; Palade P; Hsieh JC
    J Cell Biochem; 2018 Jan; 119(1):69-80. PubMed ID: 28543886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.
    Cortez V; Mann M; Tekmal S; Suzuki T; Miyata N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Vadlamudi RK
    Breast Cancer Res; 2012 Jul; 14(4):R108. PubMed ID: 22812534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of histone demethylases and histone methyltransferases in triple-negative breast cancer: Epigenetic mnemonics.
    Mandumpala JJ; Baby S; Tom AA; Godugu C; Shankaraiah N
    Life Sci; 2022 Mar; 292():120321. PubMed ID: 35031259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Implications of Epigenetic Signaling in Breast Cancer.
    Oh TG; Wang SM; Muscat GE
    Endocrinology; 2017 Mar; 158(3):431-447. PubMed ID: 27983866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between epigenetics and metabolism-Yin and Yang of histone demethylases and methyltransferases in cancer.
    Filipp FV
    Brief Funct Genomics; 2017 Nov; 16(6):320-325. PubMed ID: 28369194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.
    Wang Q; Ma S; Song N; Li X; Liu L; Yang S; Ding X; Shan L; Zhou X; Su D; Wang Y; Zhang Q; Liu X; Yu N; Zhang K; Shang Y; Yao Z; Shi L
    J Clin Invest; 2016 Jun; 126(6):2205-20. PubMed ID: 27183383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of adipogenesis by histone-modifying enzymes.
    Macchia PE; Nettore IC; Franchini F; Santana-Viera L; Ungaro P
    Epigenomics; 2021 Feb; 13(3):235-251. PubMed ID: 33502245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
    Boila LD; Sengupta A
    Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
    Patani N; Jiang WG; Newbold RF; Mokbel K
    Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of nuclear receptors and histone methylation modifying genes in the testis: implications for endocrine disruptor modes of action.
    Anderson AM; Carter KW; Anderson D; Wise MJ
    PLoS One; 2012; 7(4):e34158. PubMed ID: 22496781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone tales: lysine methylation, a protagonist in Arabidopsis development.
    Cheng K; Xu Y; Yang C; Ouellette L; Niu L; Zhou X; Chu L; Zhuang F; Liu J; Wu H; Charron JB; Luo M
    J Exp Bot; 2020 Jan; 71(3):793-807. PubMed ID: 31560751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.
    Kim JH; Sharma A; Dhar SS; Lee SH; Gu B; Chan CH; Lin HK; Lee MG
    Cancer Res; 2014 Mar; 74(6):1705-17. PubMed ID: 24491801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.
    Katz TA; Vasilatos SN; Harrington E; Oesterreich S; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2014 Jul; 146(1):99-108. PubMed ID: 24924415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.